Free testing and treatment program for chlamydia, gonorrhea, syphilis, and HIV
Official title: A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities in Black Youth Living in the Deep South
Run by Tulane University · NCT06428643 · Data updated 2026-11-12
This program offers free testing for four STIs and provides counseling and no-cost expedited treatment options for Black people aged 15–26 who live or spend most of their time in Orleans Parish.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 26 Years |
| Sex | All |
| Enrollment | 2322 (estimated) |
| Sponsor | Tulane University Academic / other |
| Locations | 1 site (New Orleans, Louisiana) |
| Status | Recruiting |
| Started | August 14, 2025 |
| Main results expected | September 1, 2028 |
| Study ends | September 1, 2029 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT06428643 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Black/African American individuals aged 15–26 who live or spend most of their time in Orleans Parish and have had vaginal sex at least once, are able to consent, and are not pregnant or known to be HIV positive.
✕Probably not a fit
People outside the 15–26 age range, non-Black individuals, known HIV-positive or pregnant people, non–English speakers, or those unable to consent would not be eligible and are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants are offered free screening for chlamydia, gonorrhea, syphilis, and HIV with one-on-one counseling and treatment options if results are positive. The program can provide no-cost expedited treatment for participants and their sexual partners and offers the option of rescreening three months after treatment. Eligible participants are Black/African American individuals aged 15–26 who live or spend most of their time in Orleans Parish and have had vaginal sex at least once; those who are pregnant, known to be HIV positive, non–English speakers, or unable to consent are excluded. The intervention is conducted at Tulane University in New Orleans in collaboration with NIH/NIAID.
Why it matters
Potential benefit: If successful, this program could increase testing and timely treatment, reduce untreated infections, and help narrow STI disparities in the local Black youth population.
How similar studies have gone: Previous seek-test-and-treat public health programs have shown success increasing detection and treatment of STIs and improving linkage to care, though partner expedited treatment outcomes have varied by setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Identifies as African American or Black * 15-26 years of age * Lives or spends most of their time in Orleans Parish * Had vaginal sex at least once * Provide a urine or vaginal swab * Not taken azithromycin or cefixime in the last 7 days Exclusion Criteria: * Unwilling or unable to provide informed consent * Unable to speak or understand English * Previously enrolled in the study
Where it's running
-
Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine
New Orleans, Louisiana, United States Recruiting
Study contacts
- Study coordinator: Patricia Kissinger, PhD
- Email: kissing@tulane.edu
- Phone: 504-988-7320
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Doxycycline Prophylaxis to Prevent STIs in Adolescent and Young Women
This trial tests whether taking doxycycline after sex or every week can reduce gonorrhea, chlamydia, and early syphilis in girls and young women, compared with usual care.
-
Improving relationship education to reduce HIV rates among sexual and gender minorities
This study is testing a new relationship education program to see if it can help reduce HIV rates among gay, bisexual, queer, and transgender individuals who are in relationships with cisgender men.
-
Observing HIV infection risks among high-risk individuals in Vienna
This study looks at the risk factors for new HIV infections among HIV-negative men who have sex with men and transgender individuals in Vienna to better understand how the virus spreads in these groups.
-
Doxycycline to prevent bacterial STIs in sexual and gender minorities in Rio de Janeiro.
This research will try taking doxycycline after sex to see if it lowers the chance of syphilis, gonorrhea, and chlamydia for men who have sex with men, transgender women, and travestis in Rio de Janeiro who are living with HIV or using PrEP.
-
Doxycycline after sex to prevent gonorrhea, chlamydia, and syphilis in MSM in Bangkok
This research tests whether taking doxycycline after sex can prevent gonorrhea, chlamydia, and syphilis in men who have sex with men in Bangkok.
-
MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis
This project will test a single blood-based point-of-care test that checks for HIV, hepatitis B and C, and syphilis using serum or plasma samples from people at sites in Ivory Coast and Kenya.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.